DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Abans Financial Services Limited — Outcome of Board Meeting

NSE 3 hrs ago·10 Aug 2026, 12:53 pm

Abans Financial Srvcs

Abans Financial Services Limited has informed the stock exchange about the release of its financial results for the quarter ending June 30, 2026. This update provides investors with the company's performance metrics, including key financial ratios and operational highlights for the period.

The release of these results is a routine corporate event that offers clarity on the company's current financial health. For investors, it serves as a crucial data point to evaluate the firm's operational efficiency and growth trajectory before making any investment decisions.

Investors should focus on the specific details provided in the financial statement, such as revenue growth and profitability. Monitoring how the stock reacts to this information will be key to understanding market sentiment towards the company's near-term prospects.